Combination Therapy of Gemcitabine and Irinotecan in Advanced Biliary Tract Cancer: Phase II Trial

被引：0
|
作者：
Chung, Moon Jae
Park, Semi
Park, Jeong Youp
Bang, Seungmin
Park, Seung Woo
Song, Si Young
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
W1896
引用
收藏
页码：S761 / S761
页数：1
相关论文
共 50 条
  • [41] A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers
    Goff, Laura W.
    Cardin, Dana B.
    Whisenant, Jennifer G.
    Du, Liping
    Koyama, Tatsuki
    Dahlman, Kimberly B.
    Salaria, Safia N.
    Young, Ruth T.
    Ciombor, Kristen K.
    Gilbert, Jill
    Smith, Stephen James
    Chan, Emily
    Berlin, Jordan
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (01) : 95 - 104
  • [42] Multicenter phase II trial of axitinib monotherapy for advanced biliary tract cancer refractory to gemcitabine-based chemotherapy
    Okaro, N.
    Ueno, M.
    Morizane, C.
    Yamanaka, T.
    Ojima, H.
    Ozaka, M.
    Sasaki, M.
    Takahara, N.
    Kobayashi, S.
    Morimoto, M.
    Hosoi, H.
    Nakai, Y.
    Ikeda, M.
    Maeno, S.
    Nagashima, F.
    Okusaka, T.
    Furuse, J.
    ANNALS OF ONCOLOGY, 2019, 30 : 283 - 283
  • [43] EXIBIT:: An international multicenter phase II trial of gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer.
    André, T.
    Reyes-Vidal, J. M.
    Fartoux, L.
    Ross, P.
    Leslie, M.
    Rosmorduc, O.
    Clemens, M. R.
    Louvet, C.
    Perez, N.
    Scheithauer, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 211S - 211S
  • [44] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
    Hwang, In Gyu
    Jang, Joung-Soon
    Oh, Sung Yong
    Lee, Suee
    Kwon, Hyuk Chan
    Lee, Gyeong Won
    Go, Seil
    Kang, Myoung Hee
    Cha, Young Joo
    Kang, Jung Hun
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (06) : 2371 - 2376
  • [45] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
    In Gyu Hwang
    Joung-Soon Jang
    Sung Yong Oh
    Suee Lee
    Hyuk Chan Kwon
    Gyeong Won Lee
    Seil Go
    Myoung Hee Kang
    Young Joo Cha
    Jung Hun Kang
    Investigational New Drugs, 2012, 30 : 2371 - 2376
  • [46] Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study
    Andre, T.
    Reyes-Vidal, J. M.
    Fartoux, L.
    Ross, P.
    Leslie, M.
    Rosmorduc, O.
    Clemens, M. R.
    Louvet, C.
    Perez, N.
    Mehmud, F.
    Scheithauer, W.
    BRITISH JOURNAL OF CANCER, 2008, 99 (06) : 862 - 867
  • [47] Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study
    T André
    J M Reyes-Vidal
    L Fartoux
    P Ross
    M Leslie
    O Rosmorduc
    M R Clemens
    C Louvet
    N Perez
    F Mehmud
    W Scheithauer
    British Journal of Cancer, 2008, 99 : 862 - 867
  • [48] Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma
    Tella, Sri Harsha
    Foster, Nathan
    Qian, Shi
    Nguyen, Tran
    Borad, Mitesh J.
    McWilliams, Robert R.
    Alberts, Steven R.
    Ma, Wen Wee
    Chakrabarti, Sakti
    Fruth, Briant
    Wessling, Jaclynn
    Hartgers, Mindy
    Washburn, Leslie
    Fernandez-Zapico, Martin E.
    Hogenson, Tara L.
    Pitot, Henry
    Jin, Zhaohui
    Mahipal, Amit
    ONCOLOGIST, 2023, 28 (10): : E917 - E966
  • [49] Irinotecan with 5-FU/FA in advanced biliary tract adenocarcinomas -: A multicenter phase II trial
    Feisthammel, Juergen
    Schoppmeyer, Konrad
    Moessner, Joachim
    Schulze, Manfred
    Caca, Karel
    Wiedmann, Marcus
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (03): : 319 - 324
  • [50] Pembrolizumab in combination with gemcitabine and cisplatin for the treatment of advanced biliary tract cancer: phase 3 KEYNOTE-966 trial in progress
    Vogel, A.
    Finn, R.
    Kelley, R.
    Furuse, J.
    Edeline, J.
    Ren, Z.
    Su, S.
    Malhotra, U.
    Siegel, A.
    Valle, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S122 - S122
12345